GB202104553D0 - Antibodies to GFRAL - Google Patents

Antibodies to GFRAL

Info

Publication number
GB202104553D0
GB202104553D0 GBGB2104553.9A GB202104553A GB202104553D0 GB 202104553 D0 GB202104553 D0 GB 202104553D0 GB 202104553 A GB202104553 A GB 202104553A GB 202104553 D0 GB202104553 D0 GB 202104553D0
Authority
GB
United Kingdom
Prior art keywords
gfral
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2104553.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kymab Ltd
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kymab Ltd filed Critical Kymab Ltd
Priority to GBGB2104553.9A priority Critical patent/GB202104553D0/en
Publication of GB202104553D0 publication Critical patent/GB202104553D0/en
Priority to PCT/EP2022/058556 priority patent/WO2022207785A1/en
Ceased legal-status Critical Current

Links

GBGB2104553.9A 2021-03-31 2021-03-31 Antibodies to GFRAL Ceased GB202104553D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2104553.9A GB202104553D0 (en) 2021-03-31 2021-03-31 Antibodies to GFRAL
PCT/EP2022/058556 WO2022207785A1 (en) 2021-03-31 2022-03-31 Antibodies to gfral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2104553.9A GB202104553D0 (en) 2021-03-31 2021-03-31 Antibodies to GFRAL

Publications (1)

Publication Number Publication Date
GB202104553D0 true GB202104553D0 (en) 2021-05-12

Family

ID=75783578

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2104553.9A Ceased GB202104553D0 (en) 2021-03-31 2021-03-31 Antibodies to GFRAL

Country Status (1)

Country Link
GB (1) GB202104553D0 (en)

Similar Documents

Publication Publication Date Title
IL276537A (en) Antibodies binding to gprc5d
IL277858A (en) Antibodies specific to human nectin4
IL287613A (en) Antibodies binding to gprc5d
ZA201905341B (en) Antibodies specifically binding to human il-1r7
EP3898698A4 (en) Antibodies specific to muc18
IL269394A (en) Antibodies binding to steap-1
ZA202104356B (en) Monoclonal antibodies that bind specifically to human trbv9
IL308741A (en) Anti-sirp-alpha antibodies
IL284807A (en) Antibodies specific to human nectin-2
EP3898964A4 (en) Antibodies specific to muc18
IL300142A (en) ANTI-IL13Ralpha2 ANTIBODIES
GB202105110D0 (en) Anti-CD73 antibodies
GB202014851D0 (en) SARS-COV-2 antibodies
GB202107330D0 (en) Antibodies to GFRAL
GB202104553D0 (en) Antibodies to GFRAL
GB2584544B (en) Improvements to letter-plates
GB202010760D0 (en) Novel antibodies
IL311043A (en) Anti-il-11rα antibodies
IL310245A (en) Anti-hla-g antibodies
GB202208773D0 (en) Anti-SARS2-S antibodies
IL308782A (en) Antibodies
IL308100A (en) Antibodies
IL307175A (en) Il-38-specific antibodies
GB202116709D0 (en) Antibodies
GB202115824D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)